Medirom receives Nasdaq delisting notice over late annual report
MRM•Medirom received a Nasdaq delisting notice after missing the extended deadline for its 2025 annual report, then filed the report and requested a hearing. A separate minimum bid price deficiency remains unresolved, with an April 5, 2027, deadline to regain compliance.




